Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 5097-5106

  Yamamoto, Yusuke ^a   Ikoma, Hisashi ^a   Morimura, Ryo ^a   Konishi, Hirotaka ^a   Murayama, Yasutoshi ^a   Komatsu, Shuhei ^a   Shiozaki, Atsushi ^a   Kuriu, Yoshiaki ^a   Kubota, Takeshi ^a   Nakanishi, Masayoshi ^a   Ichikawa, Daisuke ^a   Fujiwara, Hitoshi ^a   Okamoto, Kazuma ^a   Sakakura, Chouhei ^a   Ochiai, Toshiya ^b   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Long term survival; Repeat hepatectomy; Transarterial chemoembolization

Indexed keywords

DOXORUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CHEMOEMBOLIZATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; TREND STUDY; TUMOR ABLATION;

HEPATECTOMY; HEPATOCELLULAR CARCINOMA; LONG-TERM SURVIVAL; REPEAT HEPATECTOMY; TRANSARTERIAL CHEMOEMBOLIZATION;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84891358259     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bosch FX, Ribes J, Diaz M and Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16, 2004.
2. Poon RT, Ng IO, Fan ST, Lai EC, Lo CM, Liu CL and Wong J: Clinicopathologic features of long-term survivors and diseasefree survivors after resection of hepatocellular carcinoma: A study of a prospective cohort. J Clin Oncol 19: 3037-3044, 2001.
3. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ and P'eng FK: Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 92: 348-355, 2005.
4. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY and Chen YF: Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 93: 600-606, 2006.
5. Poon RT, Fan ST and Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24, 2000.
6. Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, Miyamoto Y, Takeshita A, Shibayama Y and Tanigawa N: Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Am Surg 77: 572-578, 2011.
7. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Arai K, Demachi H, Miyayama S, Takashima T, Unoura M and Kogayashi K: Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188: 79-83, 1993.
8. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, Moriyama N, Okusaka T, Okada S and Ueno H: Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176: 681- 688, 2001.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-649, 1973.
10. Couinaud C: Lobe et segments hepatiques. Presse Med 62: 709-12, 1954.
11. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S and Kawasaki S: Surgery for small liver cancers. Semin Surg Oncol 9: 298-304, 1993.
12. Liver Cancer study Group of Japan: General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Second English Edition: Tokyo, Kanehara, pp. 13-28, 2003.
13. Sobin LH. TNM: classifcation of malignant tumours. In: Wittekind C (ed.). International Union Against Cancer (UICC). Sixth Edition, New York, Wiley pp. 93-96, 2002.
14. Seldinger SI: Catheter replacement of the needle in percutaneous arteriography: A new technique. Acta Radiol 39: 368-76, 1953.
15. Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, and Aloia TA: Improved long-term survival after major resection for hepatocellular carcinoma: A multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg 17: 66-77, 2013.
16. The Liver Cancer Study Group of Japan: Report of the 12th Follow-up Survey of Primary Liver Cancer. Kyoto: Shinkouinsatsu Press, p. 100, 1996.
17. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M and Yamaoka Y: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131: 461-469, 2006.
18. Wu D, Rosner GL and Broemeling LD: Bayesian inference for the lead time in periodic cancer screening. Biometrics 63: 873- 880, 2007.
19. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K and Yamasaki S: Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28: 1241-1246, 1998.
20. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H and Hirohashi S: Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163: 345-351, 1987.
21. Savastano S, Miotto D, Casarrubea G, Teso S, Chiesura-Corona M and Feltrin GP: Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: A multivariate analysis of prognostic factors. J Clin Gastroenterol 28: 334-40, 1999.
22. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Yanaga K and Sugimachi K: Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227: 80-85, 1998.
23. Poon RT, Fan ST, Lo CM, Liu CL and Wong J: Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 229: 216-222, 1999.
24. Minagawa M, Makuuchi M, Takayama T and Kokudo N: Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238: 703-710, 2003.
25. Ochiai T, Sonoyama T, Kikuchi S, Konishi H, Kitagawa M, Okayama T, Ichikawa D, Ueda Y, Otsuji E and Yamagishi H: Results of repeated hepatectomy for recurrent hepatocellular carcinoma. Hepatogastroenterology 54: 858-861, 2007.
26. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H and Kosuge T: Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 34: 707-713, 2001.
27. Lau WY, Leung TW, Yu SC and Ho SK: Percutaneous local ablative therapy for hepatocellular carcinoma: A review and look into the future. Ann Surg 237: 171-179, 2003.
28. Shimada K, Sakamoto Y, Esaki M, Kosuge T, Morizane C, Ikeda M, Ueno H, Okusaka T, Arai Y and Takayasu K: Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 14: 2337-2347, 2007.
29. Ochiai T, Sonoyama T, Hironaka T and Yamagishi H: Hepatectomy with chemoembolization for treatment of hepatocellular carcinoma. Hepatogastroenterology 50: 750-755, 2003.
30. Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S and Mori M: Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol 32: 773- 779, 2006.
31. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ and P'eng FK: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82: 122-126, 1995.
32. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, Lau WY and Wu MC: A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249: 195-202, 2009.
33. Kaibori M, Tanigawa N, Kariya S, Ikeda H, Nakahashi Y, Hirohara J, Koreeda C, Seki T, Sawada S, Okazaki K and Kwon AH: A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma. Dig Dis Sci 57: 1404-1412, 2012.
34. Otsubo T, Takasaki K, Yamamoto M, Katsuragawa H, Katagiri S, Yoshitoshi K, Hamano M, Ariizumi S and Kotera Y: Bleeding during hepatectomy can be reduced by clamping the inferior vena cava below the liver. Surgery 135: 67-73, 2004.
35. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S and Makuuchi M: Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 115: 303- 309, 1994.
36. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH and Dematteo RP: Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249: 617-23, 2009.
37. Cole P and Morrison AS: Basic issues in population screening for cancer: J Natl Cancer Inst 64: 1263-1272, 1980.